ROCHELLE REECH: Open Payments
NPI 1578945093 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 25 payments from 10 companies in 2025. Trend: 2023 $1,187 · 2024 $1,265 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $241 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| SCILEX PHARMACEUTICALS INC. | 3 | $57 |
| Virtus Pharmaceuticals LLC | 2 | $42 |
| Abbott Laboratories | 2 | $33 |
| Globus Medical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $15 |
Products named: General - Pain Management, Intracept, Belbuca, ZTLido, LEVORPHANOL TARTRATE, PROCLAIM, Senza, RELISTOR.
Industry payments across LA — which companies pay providers there.
